These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2544241)

  • 1. Fluconazole and phenytoin: a predictable interaction.
    Mitchell AS; Holland JT
    BMJ; 1989 May; 298(6683):1315. PubMed ID: 2544241
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of fluconazole and cyclosporine.
    Sugar AM; Saunders C; Idelson BA; Bernard DB
    Ann Intern Med; 1989 May; 110(10):844. PubMed ID: 2540690
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
    Krishna G; Sansone-Parsons A; Kantesaria B
    Curr Med Res Opin; 2007 Jun; 23(6):1415-22. PubMed ID: 17559737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole.
    Kidd D; Ranaghan EA; Morris TC
    Lancet; 1989 May; 1(8645):1017. PubMed ID: 2565490
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluconazole-induced symptomatic phenytoin toxicity.
    Cadle RM; Zenon GJ; Rodriguez-Barradas MC; Hamill RJ
    Ann Pharmacother; 1994 Feb; 28(2):191-5. PubMed ID: 8173131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of triazole antifungal drugs in patients with cancer.
    Cronin S; Chandrasekar PH
    J Antimicrob Chemother; 2010 Mar; 65(3):410-6. PubMed ID: 20035021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole prophylaxis in hematologic cancer.
    Krause DS
    N Engl J Med; 2007 May; 356(21):2215; author reply 2215-8. PubMed ID: 17526091
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of aspergillosis.
    Karthaus M
    Clin Infect Dis; 2008 Aug; 47(3):427; author reply 427-8. PubMed ID: 18605908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional and emerging antifungal therapies.
    Arnold TM; Dotson E; Sarosi GA; Hage CA
    Proc Am Thorac Soc; 2010 May; 7(3):222-8. PubMed ID: 20463252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Voriconazole safety: short review of clinical data].
    Veselov AV; Belousov DIu
    Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential fluconazole-induced carbamazepine toxicity.
    Nair DR; Morris HH
    Ann Pharmacother; 1999; 33(7-8):790-2. PubMed ID: 10466905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
    Chen L; Zhu L; Li M; Li N; Qi F; Wang N
    AAPS PharmSciTech; 2019 Jan; 20(1):24. PubMed ID: 30604153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of fluconazole on deep-seated fungal infections].
    Ikemoto H; Watanabe K; Mori T; Taniuchi A; Akahonai Y; Mikuni C; Yoshida K; Kasai M; Kawamura K; Yoshida T
    Jpn J Antibiot; 1989 Jan; 42(1):63-116. PubMed ID: 2540369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
    Tsubokura M; Miura Y; Itokawa T; Murata K; Takei N; Higaki T; Murashige N; Kami M; Komatsu T
    J Clin Pharmacol; 2011 Oct; 51(10):1488-90. PubMed ID: 21098688
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fluconazole with cyclosporin.
    Collignon P; Hurley B; Mitchell D
    Lancet; 1989 Jun; 1(8649):1262. PubMed ID: 2566800
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
    Viljoen J; Azie N; Schmitt-Hoffmann AH; Ghannoum M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1671-9. PubMed ID: 25561337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic antifungal agents. Drug interactions of clinical significance.
    Albengres E; Le Louët H; Tillement JP
    Drug Saf; 1998 Feb; 18(2):83-97. PubMed ID: 9512916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.